Canopy Growth Corporation CGC shares are trading higher Monday, and the stock is up by more than 20% over the last five days.
What To Know:
Canopy Growth announced on Friday that it has completed the sale of BioSteel Canada and BioSteel Manufacturing, LLC resulting in gross proceeds of $30.4 million.
The company stated that a portion of proceeds realized from the sale will be used to repay debt, which is expected to further reduce interest expenses.
Cannabis investors are anticipating a vote from German lawmakers next week on a measure that could legalize the use and cultivation of recreational marijuana in Germany. Canopy Growth has a German subsidiary, Canopy Growth Germany GmbH, supplying medical marijuana under the brand Canopy Medical.
According to data from Benzinga Pro, shares of CGC are trading above the stock's 50-day moving average of 63 cents, yet well-below its 52-week high low of $4.76.
Related News: What's Going On With Bitcoin-Miner Hut 8 Mining Stock?
CGC Price Action: According to Benzinga Pro, Canopy Growth shares are up by 8.5% at 67 cents at the time of publication.
Image: Dee from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.